Long-Term Outcome of Thrombolytic Therapy for Massive Pulmonary Embolism in Pregnancy
نویسندگان
چکیده
منابع مشابه
In-hospital and long-term outcome after sub-massive and massive pulmonary embolism submitted to thrombolytic therapy.
BACKGROUND From a registry of 249 confirmed pulmonary embolism (PE) patients submitted to thrombolytic therapy (TT), we analysed predictors of in-hospital course and long-term mortality. METHODS AND RESULTS The combined clinical end point of in-hospital course associated death, recurrent PE, repeat thrombolysis, surgical embolectomy or bleeding complications. The long-term follow-up included ...
متن کاملoutcome of sub-massive pulmonary thromboemboli in patients who received thrombolytic and or non-thrombolytic therapy
background thrombolytic therapy in patients with sub-massive pulmonary embolism (smpte) needs further assessment. objectives the current study aimed to assess a potential benefit of thrombolytic and non-thrombolytic therapy in patients with smpte. patients and methods one hundred-nineteen patients were enrolled with smpte from 2006 to 2010 in the tertiary care center of rajaie medical and resea...
متن کاملLong-term outcome of pulmonary embolism.
PURPOSE OF REVIEW Until recently, little was known about the long-term outcome of pulmonary embolism. Long-term mortality and recurrence rates, the case fatality rate of recurrent events, and the frequency of persistent vascular defects remained largely unknown. Improvements in our knowledge of these aspects may help to define the optimal long-term treatment of pulmonary embolism. This review w...
متن کاملPulmonary Embolism Thrombolytic Therapy of Pulmonary Embolism A Meta-Analysis
OBJECTIVES We sought to assess the efficacy and safety of thrombolytic therapy in patients with an acute pulmonary embolism (PE). BACKGROUND Thrombolytic therapy is approved for the treatment of acute PE; however, the safety and efficacy of this therapy remain debated. METHODS A meta-analysis of randomized, controlled trials comparing thrombolytic agents with intravenous heparin in patients wit...
متن کاملLong-term therapy of pulmonary embolism.
For the majority of patients with pulmonary embolism the recommended therapy consists of a 5 to 7 day treatment with heparin followed by a treatment with oral anticoagulants given for at least 3 months. The currently recommended duration of oral anticoagulant treatment for pulmonary embolism is the result of the balance between the benefit provided by treatment, essentially the prevention of re...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Case Reports in Cardiology
سال: 2020
ISSN: 2090-6404,2090-6412
DOI: 10.1155/2020/9153618